DLP 30 mg (Capsule (Enteric Coated))

Unit Price: ৳ 10.00 (3 x 10: ৳ 300.00)
Strip Price: ৳ 100.00

Medicine Details

Category Details
Generic Dexlansoprazole
Company General pharmaceuticals ltd
Also available as
Dlp 60 mg capsule

Title

  • Dexlansoprazole Delayed-Release Capsule

Categories

  • Proton Pump Inhibitor
  • Gastrointestinal Medication
  • Acid Reducer
  • Digestive Health

Description

  • Indicated for healing of erosive esophagitis for up to 8 weeks
  • Indicated for maintenance of healed erosive esophagitis for up to 6 months
  • Indicated for symptomatic non-erosive Gastroesophageal Reflux Disease (GERD) for 4 weeks
  • Suppresses gastric acid secretion by specific inhibition of (H+/K+)-ATPase
  • Supplies as Dual Delayed Release (DDR) formulation in a capsule for oral administration
  • Contains a mixture of two types of enteric coated granules with different pH-dependent dissolution profiles
  • Plasma concentration-time profile with two distinct peaks
  • Metabolized in the liver and excreated by urine
  • Dosage recommendations for healing of erosive esophagitis and relief of heartburn
  • Dosage recommendations for maintenance of healed erosive esophagitis and relief of heartburn
  • Dosage recommendations for symptomatic non-erosive GERD
  • Can be taken without regard to food
  • Should be swallowed whole
  • Can be administered by sprinkling intact granules on one tablespoon and swallowing immediately
  • Granules should not be chewed
  • Interaction with medicines like Atazanavir, Warfarin, Tacrolimus, Clopidogrel & Methotrexate
  • Common side effects include diarrhea, abdominal pain, nausea, vomiting & flatulence
  • Pregnancy Category B
  • No adequate and well-controlled studies with Dexlansoprazole in pregnant women
  • No adequate and well-controlled studies with Dexlansoprazole in lactating mothers
  • Precautions and warnings for gastric malignancy, Clostridium difficile Associated Diarrhea, bone fracture, hypomagnesemia, and concomitant use with Methotrexate
  • No established safety and effectiveness in patients below 12 years of age
  • No dose adjustment necessary for elderly patients
  • No dose adjustment necessary for patients with renal impairment
  • Dose adjustment considerations for patients with hepatic impairment
  • No reports of significant overdose
  • Therapeutic class: Proton Pump Inhibitor
  • Store below 30°C in a dry place, protected from light

Related Brands